SCOPUS 정보 검색 플랫폼

Volumn 32, Issue 2, 2000, Pages 400-404

The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C

(5) Gordon, Stuart C a,d Fang, Jane W b Silverman, Ann L a,d McHutchison, John G c Albrecht, Janice K b

a WILLIAM BEAUMONT HOSPITAL (United States)

b MERCK RESEARCH LABORATORIES (United States)

c SCRIPPS CLINIC (United States)

d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; PLACEBO; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0033853927 PISSN: 02709139 EISSN: None Source Type: Journal
DOI: 10.1053/jhep.2000.9321 Document Type: Article

Times cited : (70)

References (27)

1
- 0022462132
- Non-A, non-B hepatitis: Evolving epidemiologic and clinical perspective
- (1986) Semin Liver Dis , vol.6 , pp. 67-81
- Dienstag, J.L.¹ Alter, H.J.²

2
- 0033431808
- Treatment of patients with chronic hepatitis C and normal ALT levels
- (1999) J Hepatol , vol.31 , Issue.SUPPL. 1 , pp. 193-196
- Tassopoulos, N.C.¹

3
- 0024368522
- Treatment of chronic hepatitis C with recombinant interferon alpha: A multicenter randomized, controlled trial
- (1989) N EngI J Med , vol.321 , pp. 1501-1506
- Davis, G.L.¹ Balart, L.A.² Schiff, E.R.³ Lindsay, K.⁴ Bodenheimer, H.C.⁵ Perillo, R.P.⁶ Carey, W.⁷

4
- 0024981607
- Recombinant interferon alpha therapy for chronic hepatitis C: A randomized, double blind, placebo-controlled trial
- (1989) N Engl J Med , vol.321 , Issue.321 , pp. 1506-1510
- DiBisceglie, A.M.¹ Martin, P.² Kassianides, C.³ Lisker-Melman, M.⁴ Murray, L.⁵ Waggoner, J.⁶ Goodman, Z.⁷

5
- 0030886964
- National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C
- National Institutes of Health
- (1997) Hepatology , vol.26 , Issue.SUPPL. 1

6
- 0032547938
- Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
- (1998) N Engl J Med , vol.339 , pp. 1485-1492
- McHutchison, J.G.¹ Gordon, S.C.² Schiff, E.R.³ Shiffman, M.L.⁴ Lee, W.M.⁵ Rustgi, V.K.⁶ Goodman, Z.⁷

7
- 0032585237
- Randomised trial of interferon alpha 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
- (1998) Lancet , vol.352 , pp. 1426-1432
- Poynard, T.¹ Marcellin, P.² Lee, S.S.³ Niederau, C.⁴ Minuk, G.S.⁵ Ideo, G.⁶ Bain, V.⁷

8
- 0028952532
- Histopathology of hepatitis C virus infection
- (1995) Semin Liver Dis , vol.15 , pp. 70-81
- Goodman, Z.D.¹ Ishak, K.G.²

9
- 0027178527
- Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
- (1993) J Gen Virol , vol.74 , pp. 1093-1102
- Stuyver, L.¹ Rossau, R.² Wuseur, A.³

10
- 17344363641
- Factors associated with serum alanine transaminase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C
- (1998) Hepatology , vol.27 , pp. 1213-1219
- Piton, A.¹ Poynard, T.² Imbert-Bismut, F.³ Khalil, L.⁴ Delattre, J.⁵ Pelissiere, E.⁶ Sansonetti, N.⁷

11
- 0030670088
- Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels
- (1997) Hepatology , vol.26 , pp. 1393-1398
- Puoti, C.¹ Magrini, A.² Stati, T.³ Rigato, P.⁴ Montagnese, F.⁵ Rossi, P.⁶ Aldegheri, L.⁷ Resta, S.⁸

12
- 0027276247
- Significance of serum hepatitis C virus RNA levels in chronic hepatitis C
- (1993) Lancet , vol.341 , pp. 1501-1504
- Lau, J.Y.N.¹ Davis, G.L.² Kniffen, J.³ Qian, Q.P.⁴ Urdea, M.S.⁵ Chan, C.S.⁶ Mizokami, M.⁷

13
- 0033030128
- A prospective, community-based evaluation of lever enzymes in individuals with hepatitis C after drug use
- (1999) Hepatology , vol.29 , pp. 590-596
- Inglesby, T.V.¹ Rai, R.² Astemborski, J.³ Gruskin, L.⁴ Nelson, K.E.⁵ Vlahov, D.⁶ Thomas, D.L.⁷

14
- 0031952915
- Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity
- (1998) Hepatology , vol.27 , pp. 868-872
- Mathurin, P.¹ Moussalli, J.² Cadranel, J.-F.³ Thibault, V.⁴ Charlotte, F.⁵ Dumouchel, P.⁶ Cazier, A.⁷

15
- 0032714315
- Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States
- (1999) Hepatology , vol.30 , pp. 1307-1311
- Jamal, M.M.¹ Soni, A.² Quinn, P.G.³ Wheeler, D.E.⁴ Arora, S.⁵ Johnston, D.E.⁶

16
- 0030933395
- Natural history of liver fibrosis progression in patients with chronic hepatitis C
- (1997) Lancet , vol.349 , pp. 825-832
- Poynard, T.¹ Bedossa, P.² Opolon, P.³

17
- 0033566684
- Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis
- (1999) Cancer , vol.86 , pp. 589-595
- Tarao, K.¹ Rino, Y.² Ohkawa, S.³ Shimizu, A.⁴ Tamai, S.⁵ Miyakawa, K.⁶ Aoki, H.⁷

18
- 0031828962
- Predictive value of aminotransferase and hepatitis B virus DNA levels on response to interferon therapy for chronic hepatitis B
- (1998) J Viral Hepat , vol.5 , pp. 171-178
- Lok, A.S.¹ Ghany, M.G.² Watson, G.³ Ayola, B.⁴

19
- 0000183272
- Predictors of HBeAg seroconversion in chronic hepatitis B patients treated with lamivudine
- (1999) Hepatology , vol.30 , Issue.SUPPL.
- Perillo, R.P.¹ Schalm, S.W.² Schiff, E.R.³ Brown, N.A.⁴ Woessner, M.A.⁵ Sullivan, M.⁶

20
- 0032869876
- Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B
- Asain Hepatitis Lamivudine Trial Group
- (1999) Hepatology , vol.30 , pp. 770-774
- Chien, R.N.¹ Liaw, Y.F.² Atkins, M.³

21
- 0030767251
- Alfa-interferon treatment of HCV RNA positive patients with normal or near-normal ALT levels
- (1997) Am J Gastroenterol , vol.92 , pp. 1793-1795
- Silverman, A.L.¹ Piquette, D.L.² Filipiak, C.L.³ Neill, J.S.⁴ Bayati, N.⁵ Gordon, S.C.⁶

22
- 0030033114
- Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity
- (1996) Gastroenterology , vol.110 , pp. 291-295
- Serfaty, L.¹ Chazouilleres, O.² Pawlotski, J.-M.³ Andreani, T.⁴ Pellet, C.⁵ Poupon, R.⁶

23
- 0031891214
- Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: A pilot randomized controlled study
- (1998) Hepatology , vol.27 , pp. 853-856
- Sangiovanni, A.¹ Morales, R.² Spinzi, G.³ Rumi, M.⁴ Casiraghi, A.⁵ Ceriani, R.⁶ Colombo, E.⁷

24
- 14444281160
- Interferon alfa-2b therapy in low-activity hepatitis C: A pilot study
- (1997) Scand J Gastroenterol , vol.32 , pp. 1256-1260
- Nordoy, I.¹ Krarup, H.B.² Bell, I.V.³ Christensen, P.B.⁴ Elgjo, B.⁵ Von der Lippe, B.⁶

25
- 0028825305
- Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: The role of interferon alpha 2b therapy
- (1995) J Hepatol , vol.23 , pp. 503-508
- Van Thiel, D.H.¹ Caraceni, P.² Molloy, P.J.³ Hassanein, T.⁴ Gurakar, A.⁵ Friedlander, L.⁶

26
- 0031980458
- Treatment of HCV positive individuals with normal serum ALT levels
- (1998) Hepatogastroenterology , vol.45 , pp. 321-324
- Van Thiel, D.H.¹ Colantoni, A.² De Maria, N.³

27
- 4243803846
- Interferon alfa-2b and ribavirin in treatment-naive patients with chronic hepatitis C and normal ALT levels
- (1999) Hepatology , vol.30 , Issue.SUPPL.
- Jacobson, I.¹ Lebovics, E.² Geders, J.³ Klion, F.⁴ Esposito, S.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.